Godoi, Manuella Machado; Zangrossi Junior, Hélio 
; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Fonte: Pharmacology Biochemistry and Behavior. Unidade: FMRP
Assuntos: ANALGÉSICOS, ÓPIO, MEDO, ÁCIDOS ARAQUIDÔNICOS, COMPORTAMENTO ANIMAL, ENCEFALINAS, CANABINOIDES, ANTAGONISTAS, SOMATOSTATINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOI, Manuella Machado et al. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception. Pharmacology Biochemistry and Behavior, v. 194, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2020.172938. Acesso em: 10 nov. 2024.APA
Godoi, M. M., Zangrossi Junior, H., Cunha, J. M. da, & Zanoveli, J. M. (2020). Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception. Pharmacology Biochemistry and Behavior, 194. doi:10.1016/j.pbb.2020.172938NLM
Godoi MM, Zangrossi Junior H, Cunha JM da, Zanoveli JM. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception [Internet]. Pharmacology Biochemistry and Behavior. 2020 ; 194[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.pbb.2020.172938Vancouver
Godoi MM, Zangrossi Junior H, Cunha JM da, Zanoveli JM. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception [Internet]. Pharmacology Biochemistry and Behavior. 2020 ; 194[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.pbb.2020.172938
